The present study aimed to determine the effect of visfatin on viability, proliferation, and apoptosis along with understanding the molecular mechanisms of the observed changes using JEG-3 and BeWo placental cell lines as well as placental explants from normal, IUGR, PE, and GDM pregnancies. The gene discussed is NAMPT; the disease is fetal growth restriction.